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Introduction
Schistosomiasis affects up to 300 million people in regions of South America, Southeast Asia,
the Middle East, Mediterranean Europe, and sub-Saharan Africa. Chronic consequences of
schistosomiasis include anemia, physical and cognitive retardation in children, and organ fail-
ure. With predilection for the genitourinary tract, Schistosoma haematobium increases the risk
of bladder cancer and HIV infection in women. Microscopic identification and enumeration of
parasite eggs in urine (S. haematobium) or stool (Schistosoma mansoni and Schistosoma japoni-
cum) has remained the standard for schistosomiasis diagnosis [1]. Limitations of microscopy
include the need for skilled personnel in the field with microscopy equipment and its time-
consuming nature. Particularly in infrastructure-limited regions, point-of-care (POC) molecu-
lar diagnostics hold the potential to transform the management of infectious diseases such as
schistosomiasis that carry significant long-term morbidity if left undiagnosed. POC diagnosis
could allow selective drug administration to individuals with confirmed infection rather than
entire schools or communities, and an integrated diagnosis–single dose therapy approach
could reduce costs of drug administration campaigns and minimize treatment-associated
adverse effects.
Electrochemical biosensors are well suited for molecular diagnostics because of their high
sensitivity, low cost, ease of integration into POC devices, and portability of the reader instru-
mentation [2]. We have developed a strategy for rapid (one hour) molecular diagnosis of bacte-
rial urinary tract infections using electrochemical biosensors [3,4]. Urinary cells are lysed and
directly applied to an array of sensors functionalized with oligonucleotide probes targeting the
16S ribosomal RNA (rRNA) of common uropathogens [3,4]. Formation of the sequence-
specific hybridization complex between the pathogen rRNA and the labeled capture and detector
probe pairs is detected by an enzyme tag that mediates an amperometric signal output (Fig 1).
In this work, we demonstrate the use of our biosensor-based platform for detection of
S. haematobium in urine. We developed capture and detector probes targeting S. haematobium
rRNA and integrated them into our established molecular diagnostics strategy. After
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determining an efficient egg lysis strategy, we demonstrated direct electrochemical detection of
S. haematobium eggs spiked in human urine.
Development and Validation of a Urine Test for S. haematobium
Probe design and analysis
Using Geneious 7.0.3 software, available rRNA sequences from GenBank, and published PCR
primers [5–7], we identified five candidate probe pairs homologous to S. haematobium 18S or
28S rRNA. Similarity searches of the probe sequences using BLAST (http://blast.ncbi.nlm.nih.
gov/Blast.cgi) indicate they likely bind other schistosome species such as S.mansoni and S.
japonicum because of the high degree of homology in their rRNA genes, but no significant
homology outside the genus Schistosoma was identified. Given only S. haematobium eggs are
generally found in urine, we determined that the sequences would confer specificity for S. hae-
matobium when testing human urine samples (Table 1).
We tested the probe pairs in our electrochemical biosensor assay with S. haematobium RNA
prepared from adult worms by the Schistosome Research Reagent Resource Center (distributed
Fig 1. Biosensor-basedmolecular detection of urinary pathogen. The biosensor is composed of three
planar gold electrodes (working, auxiliary, and reference). For the biosensor assay, capture probes are
bound to the surface of the working electrode via a thiol linkage. Cells in the sample are lysed and mixed with
a buffered solution of detector probe, then applied to the sensor surface. If the target rRNA is present, a
hybridization complex of target, capture, and detector probes forms. This complex is detected by binding of
horseradish peroxidase (HRP)-conjugated antifluorescein binding to a fluorescein tag on the detector probe
and addition of tetramethylbenzidine (TMB) substrate. The electron transport mediated by the HRP is
measured amperometerically, and the signal is proportional to the quantity of the target.
doi:10.1371/journal.pntd.0003845.g001
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by BEI Resources). Standard chip arrays consisting of 16 electrochemical sensors were pur-
chased from GeneFluidics (Irwindale, USA). The individual sensors were functionalized with
thiolated capture probes and positive and negative control sequences as previously described
[8], and the biosensor assay was conducted as previously reported [4]. Hybridization to S. hae-
matobium 18S rRNA (18S323, 18S758C) and 28S rRNA (28S495, 28S521, and 28S693) probes
Table 1. Sequences of capture and detector probe pairs tested for detection of S. hematobiuma.
Probe name Sequence (5'-3')b
18SH323
Capture AAGTTATCCAGAGTCATCACAG
Detector AATGTARCAGGCACAGCCGAAG
18SH758
Capture TCCTGATCGTAACCAAAACCGT
Detector GAACAAGCAGCGGCATGCGACC
28SH495
Capture CGACTCCAAGGGTAGCTCAGAR
Detector CARAACTGTCACACTTGATCTC
28SH521
Capture ACTTTGGGCTGCATTCACAAAC
Detector AACCCGACTCCAAGGGTAGCTC
28SH693
Capture CACACTCATCAGCTGAATTC
Detector CCAGAGCTTGCAGTTCAACTC
PC1
Capture ACTACCTACAATAAAAAACTCC
Detector AAAAATAAGTCGCACAAACATC
NC1
Capture TCCCACACCCCACGATACAAAA
a The capture probes were modified with 5’ thiol, and detector probes were modified with 3’ fluorescein.
b The degenerate base “R” represents either A or G.
doi:10.1371/journal.pntd.0003845.t001
Fig 2. S. haematobium probe testing. A. Sensors were functionalized with the different candidate capture probes for S. haematobium detection or positive
and negative control probes. A 25 ng/μl solution of total RNA with the appropriate matching detector probe was applied to sensors with candidate probes, a
0.5 nM solution of synthetic target with matching detector probe was applied to sensors for positive control, and a hybridization solution with no target was
applied to negative control sensors. The highest signal of 5237 nA for the 28S495 probe set indicated this probe would give the best sensitivity for S.
haematobium detection.B. To determine the limit of detection for the 28S495 probe set, all sensors on the chip were functionalized with the 28S495 capture
probe. Serial dilutions of S. haematobium total RNA were applied to the sensors for assay.
doi:10.1371/journal.pntd.0003845.g002
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was tested at 50°C. The 28S495 probe pair yielded the highest signal in the biosensor assay
(Fig 2A) and was chosen for further assay development.
Ethics statement
All animal procedures were conducted according Administrative Panel on Laboratory Animal
Care (APLAC) approved protocol #22502 and Veterinary Service Center institutional guide-
lines of Stanford University (Animal Welfare Assurance A3213-01 and USDA License 93-4R-
00). For S. haematobium egg isolation, each hamster was anesthetized with an intraperitoneal
injection of 500 μL of a 0.504 mg (100.8 units/mL) solution of heparin sodium (Sigma-Aldrich)
and 26 mg/mL sodium pentobarbital. Once under deep general anesthesia (including no with-
drawal responses to paw pinch), each hamster underwent a combined thoracotomy and lapa-
rotomy for euthanasia and to expose the abdominal viscera. The liver and intestines of each
hamster were harvested, and S. haematobium eggs were isolated.
Analytical sensitivity of the electrochemical biosensor assay with S.
haematobium egg RNA
To verify the analytical sensitivity of the probe pairs, we isolated total RNA directly from S.
haematobium eggs. Tissues from S. haematobium-infected Lakeview Golden (LVG) hamsters
obtained from the Schistosomiasis Research Reagent Resource Center (Biomedical Research
Institute, Rockville, Maryland) were harvested for egg isolation at approximately 18 weeks
postinfection [9]. After harvesting, S. haematobium eggs were preserved in RNA Later
(Ambion, Life Technologies). Total RNA from approximately 8,000 eggs was extracted using
Trizol Reagent (Ambion, Life Technologies, USA) according to manufacturers' instructions.
To determine the limit of detection (LOD) of the biosensor assay for S. haematobium egg
RNA, serial dilutions of the purified RNA were prepared and tested. Using the 28S495 probe
pair, as little as 0.53 ng/μl total egg RNA from S. haematobium egg rRNA was detected in the
biosensor assay (Fig 2B).
Direct detection of 28S rRNA from S. haematobium eggs
Next, we tested different egg lysing strategies to enable direct detection of S. haematobium
rRNA in the crude lysate using the biosensor assay. Mechanical lysis offers high versatility and
is amenable to integration in diagnostic devices [10]. We compared two different lysis strate-
gies: glass bead agitation and sonication.
For each lysis protocol, approximately 106 eggs were suspended in 500 μl lysis buffer [0.1%
Triton X-100, 20 mM tris-HCl (pH 8.0), 2 mM EDTA (pH 8.0)] in a 1.5 ml tube. For glass
bead agitation, 10–15 glass beads, (1 mm diameter, Sigma-Aldrich) were added to the tube con-
taining eggs in lysis buffer then vigorously vortexed for 2 min. The beads were allowed to settle
and the lysate removed for assay. For sonication, the eggs suspended in lysis buffer were sub-
jected to two 10-sec pulses with a probe sonicator (Sonic Dismembrator Model 100, Fisher Sci-
entific) at output power of 4–5 RMS with 10 sec on ice between sonication to prevent excess
RNA damage. To avoid cross-contamination, the sonicator probe was cleaned with isopropa-
nol between uses. The crude lysate was then used in a biosensor assay. Starting with the same
number of eggs for both lysis protocols, the biosensor signal was 3.3-fold higher after lysis by
sonication compared to agitation with glass beads (Fig 3A). The data suggest that sonication
yield more efficient liberation of rRNA from the schistosome eggs and was used for lysis in sub-
sequent experiments.
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Detection of S. haematobium eggs in urine with electrokinetic-facilitated
hybridization
Previously, we integrated alternating current (AC) electrokinetics to improve direct electro-
chemical detection of bacterial pathogens in urine [8,11]. By inducing bulk fluid motion and
local heating, AC electrokinetics improved overall signal-to-noise of the biosensor assay. Fur-
ther, implementation of electrokinetics will facilitate integration into a POC device as it obvi-
ates the need for an external incubator for hybridization. For schistosomal detection, we
applied square wave AC potential across the working and auxiliary electrodes of the electro-
chemical sensors using a function generator (HP, 33210A) and a setting of 200 kHz, 7 Vpp for
15 minutes. We determined the LOD of S. haematobium eggs in human urine with probe pair
28S495 with electrokinetics-facilitated hybridization. Urine containing S. haematobium eggs
was sonicated and serially diluted in the urine sample, and dilutions were tested in the biosen-
sor assay. The LOD was approximately 30 eggs/ml urine in the biosensor assay. However, opti-
mization of sensitivity, possibly through concentration of eggs in urine or biosensor probe
modification, will be necessary for detection of light infections where as few as 2–3 eggs/ml
may be present in urine [12].
Conclusion
This study is an important step toward development of a POC device for rapid detection of
S. haematobium eggs in urine (Box 1). We have implemented strategies that will aid in device
integration, such as mechanical lysis and AC electrokinetics. For future development, we will
integrate this core assay into a fully automated microfluidics cartridge, further optimize the
detection sensitivity, and validate with clinical samples.
Sequence numbers
Biosensor probes based on GenBank sequences Z11976.1 and Z46521.
Fig 3. Detection of S. haematobium eggs. A. S. haematobium eggs spiked in human urine were lysed by agitation with glass beads or sonication and the
crude lysate tested in the biosensor assay with the 28S495 probe set with positive and negative controls as described in Fig 2. The higher signal with
sonication compared to glass beads indicates more efficient cell lysis. B. To determine the LOD for detection of S. haematobium eggs in urine in the
biosensor assay, a sample of 106 egg/ml was lysed by sonication and serially diluted in urine. Biosensor assay detection of S. haematobium eggs with the
28S495 probe set indicated an LOD of approximately 30 eggs/ml.
doi:10.1371/journal.pntd.0003845.g003
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